• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜异位症与卵巢癌:临床、病理和分子方面的综述。

Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects.

机构信息

Department of Pathology, Division of Reproductive Biology Research, Northwestern University Feinberg School of Medicine, 251 E. Huron St., Chicago, IL, 60611, USA.

出版信息

Int J Gynecol Pathol. 2011 Nov;30(6):553-68. doi: 10.1097/PGP.0b013e31821f4b85.

DOI:10.1097/PGP.0b013e31821f4b85
PMID:21979592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4130217/
Abstract

Endometriosis is a chronic disease that affects millions of reproductive-age women. Despite the destructive and invasive nature of endometrioses, most cases are perpetually benign or eventually regress; however, atypical endometriosis is a precursor lesion and can lead to certain types of ovarian cancer. Endometriosis induced inflammation and auto- and paracrine production of sex steroid hormones contribute to ovarian tumorigenesis. These changes provide microenvironment necessary to accumulate enough genetic alterations for endometriosis associated malignant transformation. It takes years for endometriosis to undergo the pathophysiological progression that begins with atypical epithelial proliferation (atypical endometriosis and metaplasia), and then is followed by the formation of well-defined borderline tumors, and finally culminates in fully malignant ovarian cancer. This study is a review of the natural history of endometriosis and the role of microenvironments that favor the accumulation of genetic alterations and endometriosis-associated ovarian cancer progression.

摘要

子宫内膜异位症是一种影响数百万育龄妇女的慢性疾病。尽管子宫内膜异位症具有破坏性和侵袭性,但大多数病例都是良性的或最终会消退;然而,非典型子宫内膜异位症是一种前驱病变,可导致某些类型的卵巢癌。子宫内膜异位症引起的炎症以及性激素的自分泌和旁分泌产生,有助于卵巢肿瘤的发生。这些变化为积累足够的遗传改变提供了微环境,从而导致与子宫内膜异位症相关的恶性转化。子宫内膜异位症要经历从非典型上皮增生(非典型子宫内膜异位症和化生)开始的病理生理进展,然后形成明确的交界性肿瘤,最后发展为完全恶性的卵巢癌,需要数年的时间。本研究综述了子宫内膜异位症的自然病史以及有利于遗传改变积累和子宫内膜异位症相关卵巢癌进展的微环境的作用。

相似文献

1
Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects.子宫内膜异位症与卵巢癌:临床、病理和分子方面的综述。
Int J Gynecol Pathol. 2011 Nov;30(6):553-68. doi: 10.1097/PGP.0b013e31821f4b85.
2
Endometriosis and ovarian cancer: clinical and molecular aspects.子宫内膜异位症与卵巢癌:临床与分子层面
Minerva Endocrinol. 2014 Sep;39(3):155-65. Epub 2014 Jul 8.
3
[The malignant potential of ovarian atypical endometriosis].[卵巢非典型子宫内膜异位症的恶性潜能]
Zhonghua Bing Li Xue Za Zhi. 2001 Jun;30(3):169-72.
4
Accumulative copy number increase of MET drives tumor development and histological progression in a subset of ovarian clear-cell adenocarcinomas.MET 累积拷贝数增加驱动卵巢透明细胞腺癌亚组的肿瘤发生和组织学进展。
Mod Pathol. 2012 Jan;25(1):122-30. doi: 10.1038/modpathol.2011.143. Epub 2011 Oct 7.
5
The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.子宫内膜异位症与卵巢癌的关联:组织学、遗传学和分子改变的综述。
Gynecol Oncol. 2012 Jan;124(1):164-9. doi: 10.1016/j.ygyno.2011.10.001. Epub 2011 Oct 26.
6
Predictive factors of endometriosis progression into ovarian cancer.内异症进展为卵巢癌的预测因素。
J Ovarian Res. 2022 Jan 10;15(1):5. doi: 10.1186/s13048-021-00940-8.
7
Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.卵巢子宫内膜异位症和透明细胞癌中ARID1A/BAF250a表达缺失。
Int J Clin Exp Pathol. 2012;5(7):642-50. Epub 2012 Sep 5.
8
[Is endometriosis a premalignant condition to ovarian carcinoma?].[子宫内膜异位症是卵巢癌的癌前病变吗?]
Duodecim. 2015;131(19):1777-84.
9
Cancer Implications for Patients with Endometriosis.子宫内膜异位症患者的癌症影响
Semin Reprod Med. 2017 Jan;35(1):110-116. doi: 10.1055/s-0036-1597120. Epub 2017 Jan 3.
10
Higher frequency of chromosomal aberrations in ovarian endometriosis compared to extragonadal endometriosis: A possible link to endometrioid adenocarcinoma.与性腺外子宫内膜异位症相比,卵巢子宫内膜异位症中染色体畸变的频率更高:与子宫内膜样腺癌的可能联系。
Mod Pathol. 2006 Dec;19(12):1615-23. doi: 10.1038/modpathol.3800699. Epub 2006 Sep 15.

引用本文的文献

1
Clinical Investigation of Recurrence, Oncological, and Obstetrical Outcomes in Patients with Ovarian Atypical Endometriosis.卵巢非典型子宫内膜异位症患者复发、肿瘤学及产科结局的临床研究
J Clin Med. 2025 Aug 10;14(16):5656. doi: 10.3390/jcm14165656.
2
Anatomic subtype-specific causal effects of endometriosis on ovarian cancer: a two-sample Mendelian randomization study.子宫内膜异位症对卵巢癌的解剖学亚型特异性因果效应:一项两样本孟德尔随机化研究。
Discov Oncol. 2025 Aug 13;16(1):1542. doi: 10.1007/s12672-025-03387-1.
3
Disease Severity- and Hormonal Status-Dependent Alterations of EGF and MIF in the Serum of Endometriosis Patients.子宫内膜异位症患者血清中表皮生长因子(EGF)和巨噬细胞移动抑制因子(MIF)随疾病严重程度和激素状态的变化
Int J Mol Sci. 2025 Jul 12;26(14):6695. doi: 10.3390/ijms26146695.
4
Case Report: Serous borderline ovarian tumor and extensive abdominopelvic endometriosis mimicking advanced epithelial ovarian cancer in a postmenopausal patient.病例报告:一名绝经后患者的浆液性交界性卵巢肿瘤及广泛的盆腔腹部子宫内膜异位症酷似晚期上皮性卵巢癌。
Front Med (Lausanne). 2025 Jun 17;12:1581241. doi: 10.3389/fmed.2025.1581241. eCollection 2025.
5
Endometriosis MDC: role of the radiologist.子宫内膜异位症多学科诊疗模式:放射科医生的作用
Abdom Radiol (NY). 2025 Apr 4. doi: 10.1007/s00261-025-04920-0.
6
LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarker.LINE-1开放阅读框1蛋白(ORF1p)表达出现在卵巢透明细胞癌前体中,是一种潜在的血液生物标志物。
NPJ Precis Oncol. 2025 Mar 6;9(1):62. doi: 10.1038/s41698-025-00849-1.
7
Somatic PTEN and ARID1A loss and endometriosis disease burden: a longitudinal study.体细胞PTEN和ARID1A缺失与子宫内膜异位症疾病负担:一项纵向研究。
Hum Reprod. 2025 Feb 1;40(2):296-309. doi: 10.1093/humrep/deae269.
8
Genetic Links between Endometriosis and Endometriosis-Associated Ovarian Cancer-A Narrative Review (Endometriosis-Associated Cancer).子宫内膜异位症与子宫内膜异位症相关卵巢癌之间的遗传联系——一篇叙述性综述(子宫内膜异位症相关癌症)
Life (Basel). 2024 May 30;14(6):704. doi: 10.3390/life14060704.
9
The "Road" to Malignant Transformation from Endometriosis to Endometriosis-Associated Ovarian Cancers (EAOCs): An mTOR-Centred Review.从子宫内膜异位症到子宫内膜异位症相关卵巢癌(EAOC)的恶性转化之路:以mTOR为中心的综述
Cancers (Basel). 2024 Jun 6;16(11):2160. doi: 10.3390/cancers16112160.
10
Molecular landscape of borderline ovarian tumours: A systematic review.卵巢交界性肿瘤的分子图谱:一项系统综述。
Open Med (Wars). 2024 Jun 7;19(1):20240976. doi: 10.1515/med-2024-0976. eCollection 2024.

本文引用的文献

1
Endocervical-like (Müllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation.卵巢的宫颈样(米勒管)黏液性交界性肿瘤常与 KRAS 突变有关。
Histopathology. 2010 Oct;57(4):587-96. doi: 10.1111/j.1365-2559.2010.03673.x.
2
ARID1A mutations in endometriosis-associated ovarian carcinomas.ARID1A 突变与子宫内膜异位症相关的卵巢癌。
N Engl J Med. 2010 Oct 14;363(16):1532-43. doi: 10.1056/NEJMoa1008433. Epub 2010 Sep 8.
3
The role of microRNAs in endometriosis and associated reproductive conditions.微小 RNA 在子宫内膜异位症及相关生殖状况中的作用。
Hum Reprod Update. 2010 Mar-Apr;16(2):142-65. doi: 10.1093/humupd/dmp034. Epub 2009 Sep 22.
4
MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis.患有和未患有子宫内膜异位症的女性在位分泌期子宫内膜的微小RNA表达谱分析
Mol Hum Reprod. 2009 Oct;15(10):625-31. doi: 10.1093/molehr/gap068. Epub 2009 Aug 19.
5
Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review).卵巢子宫内膜异位症相关透明细胞癌的分子发病机制(综述)
Oncol Rep. 2009 Aug;22(2):233-40.
6
Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases.卵巢子宫内膜样腺癌的发病机制途径:29例分子研究
Am J Surg Pathol. 2009 Aug;33(8):1157-63. doi: 10.1097/PAS.0b013e3181a902e1.
7
Clinical manifestations in patients with ovarian clear cell carcinoma with or without co-existing endometriosis.卵巢透明细胞癌伴或不伴并存子宫内膜异位症患者的临床表现。
Gynecol Endocrinol. 2009 Jul;25(7):435-40. doi: 10.1080/09513590902770131.
8
Defining the cut point between low-grade and high-grade ovarian serous carcinomas: a clinicopathologic and molecular genetic analysis.定义低级别和高级别卵巢浆液性癌之间的切点:一项临床病理和分子遗传学分析。
Am J Surg Pathol. 2009 Aug;33(8):1220-4. doi: 10.1097/PAS.0b013e3181a24354.
9
KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay.使用高灵敏度生物芯片检测法对卵巢样本进行KRAS突变分析。
BMC Cancer. 2009 Apr 9;9:111. doi: 10.1186/1471-2407-9-111.
10
Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.卵巢透明细胞癌中PIK3CA的频繁激活突变。
Am J Pathol. 2009 May;174(5):1597-601. doi: 10.2353/ajpath.2009.081000. Epub 2009 Apr 6.